Webinar: Psychosocial Aspects of Pituitary Disease

Jessica Diller Martino
Professor – History of Psychology
City University of New York

Register Now!

After registering you will receive a confirmation email with details about joining the webinar.

Contact us at webinar@pituitary.org with any questions or suggestions.

Date: Thursday, March 19, 2015
Time: 10:00 AM – 11:00 AM Pacific Standard Time

Webinar Description:

Please join us on March 19th for a webinar on a topic that is too often ignored: the mental health of pituitary patients. Jessica Diller Kovler, Professor in the History of Psychology at the City University of New York, will join us to discuss psychosocial aspects of pituitary disease.

Learn about the symptoms before and after diagnosis, which symptoms are observed in each type of pituitary dysfunction, and learn ways to cope and connect with others.

Presenter Bio:

Jessica Diller Kovler is a Professor in the History of Psychology at the City University of New York, where she is researching psychosocial aspects of pituitary disease. She is also a medical journalist and former reporter for The New York Times, and has worked collaboratively with the Pituitary Network Association for over a decade.

2015 Tribute to Champions of Hope Community Nominated Awards

global-champions

 

It’s that time of year again, when the rare disease community looks amongst themselves to identify and nominate agents of change, agents of innovation, and individuals who are working tirelessly on behalf of those affected by one of the 7,000 rare diseases impacting over 350 million people worldwide. Rare disease activists come from many different disciplines and are usually not recognized for the good work that they are doing. This is our opportunity as a community to come together to celebrate and honor those who are setting higher standards, making significant changes and fearlessly attacking challenges differently. Join Global Genes in recognizing these incredible individuals by nominating your Champion of Hope today.

All nominees will receive a special recognition gift, and those who win, will be asked to join us in Southern California in September at the Tribute To Champions of Hope Gala. Winners must be available Friday, September 25 and Saturday, September 26. 

 

Nomination Categories

RARE Champion in Medical Care & Treatment

Nominations are being accepted for health care providers who are recognized innovators in clinical care and treatment for rare disease. This nominee engages with patients/families to optimize care and treatment, and has become a leader in care for the specific patient population. Special consideration will be given to those individuals who have created cutting edge programs and support well beyond the current standards of care.

 

RARE Champion in Science

Nominations are being accepted for researchers who are recognized innovators & leaders in disease specific research, drug development, and scientific process. This person or group works to advance research for a specific rare disease or is a key agent in the provision of tolls and approaches to developing and/or delivering more effective treatments for the rare disease community. Nominees should be conducting research in academia, industry, the clinic, within an advocacy organization or patient driven.

 

 RARE Champion in Advocacy

Nominations are being accepted for individuals either in rare disease or within the general public who have been involved in a program, event, legislative effort, or something else extraordinary to advocate for rare disease patients and their families. Nominees could include patients, patient advocates, celebrity, legislators, professional/Olympic athletes, etc.

  

RARE Champion in Teen Advocacy

Nominations are being accepted for young adults that have been instrumental in advocating for a rare disease.   We are looking for a patient or patient advocate who has been involved in a program, event, legislative effort, or something else extraordinary to advocate for rare disease patients, their families or even themselves. 

 

RARE Champion – Collaborations in Advocacy

In order to advance efforts related to advocacy, we are finding that collaborations are critical and necessary to ensure success for rare disease. We are looking to honor organizations and individuals who have demonstrated a successful collaboration related to rare disease advocacy.   This award should not include scientific collaborations, but rather should focus on collaborative programs and support initiatives, the development of collaborative resources and tools that create impact, collaboration around legislative efforts, collaborations around events, awareness efforts,etc.   Submissions must include the names and contact information for all participating individuals or organizations.

 

RARE Champion – Collaborations in Science & Technology

In order to advance efforts related to rare disease research, we are finding collaborations are critical to ensure success.   Nominees for this award will have had demonstrated success in advancing science for a disease or family of diseases by creating novel collaborations through science, driven by science collaborations set forth by advocacy organizations, or through a combination of both. Consideration will be given to new ideas working to drive systemic change within the science community through novel collaborations. Submissions must include names and contact information for all parties involved.

 Nominations open March 15.

***Award Recipients are not based on number of submissions. All nominations will be reviewed and winner decided by the Global Genes Award Committee***

2015 Community Nominated Awards for the Tribute to Champions of Hope Gala will be open for submissions starting March 15th!

We are looking to YOU to nominate those individuals and organizations who are making a difference in your rare disease community.

Nominations close on April 30th.  Awards will be determined by nominees’ merit, not by number of submissions.

Ohio Pituitary Patient Symposium at OSU and Gentle Giant Awards Dinner

Please join the Pituitary Network Association and The Ohio State University for a Pituitary Patient Symposium featuring a series of pituitary and hormonal patient education seminars presented by some of the top physicians of pituitary and hormonal medicine. The symposium faculty will share the most up-to-date information and be available to answer your most pressing questions.

Following the Patient Symposium you are cordially invited to attend Pituitary Network Association’s Gentle Giant Award Reception and Dinner. Join us in honoring Dr. Daniel Prevedello for his exemplary accomplishments in the field of pituitary medicine.  Dr. Prevedello is an Associate Professor of Neurosurgery at The Ohio State University Wexner Medical center and Director of OSU’S Minimally Invasive Cranial Surgery Program.  Dr. Prevedello is internationally recognized in the field of minimally invasive surgery for brain, pituitary, and skull based tumors and has been a member of Best Doctors of America the last five years.  As a practicing neurosurgeon for over 15 years, Dr. Prevedello has performed over 1,800 procedures of which, over 800 were using the Endoscopic Endonasal Approach.  His current surgical practice encompasses the full spectrum of brain and skull based tumors, both benign and malignant, treated with minimally invasive and conventional approaches.

Registration is available for one or both events. The Patient Symposium registration fee is $30 and includes continental breakfast and lunch*. The Award Reception and Dinner is $50 per person or $80 for two (bring a friend or loved one and receive a discount of $20 on the purchase of 2 tickets).

 

*This registration is for the Patient Symposium only. The Ohio State University is offering a CME Course separate from our Symposium. For information on the CME course go to ccme.osu.edu

Date:  April 18, 2015

Fawcett Event Center
Ohio State University
Columbus, OH

Registration and Continental Breakfast 8:00 – 9:00am

Opening remarks 9:00am – Dr. Prevedello

Pituitary Disorders and the Effects on the Family

Epidemiology of Pituitary Tumors

Defining Clinically Significant Pituitary Disease

Treatment Options: Surgery

State of the Art Surgery for Cushing’s Disease

Question and Answer Session with Morning Symposium Faculty

Lunch with guest patient speakers: Concetta Troskie, Lori Burkhoff

Sexual Dysfunction and Infertility

Acromegaly

Pituitary Trivial Pursuit

Psychosocial Aspects of Pituitary Disease

Pituitary Disease and Your Symptoms

Question and Answer Session with Afternoon Symposium Faculty

Closing Remarks – Dr. Prevedello

Symposium Adjourns 5:45pm

2015 Champions of Hope Nominations Open March 15!

global-champions

DO YOU KNOW A RARE CHAMPION OF HOPE WHO DESERVES PUBLIC RECOGNITION?
If so, we want hear from you!
2015 Community Nominated Awards for the Tribute to Champions of Hope Gala will be open for submissions starting March 15th! We are looking to YOU to nominate those individuals and organizations who are making a difference in your rare disease community.
The six nomination categories are:
·         RARE Champion in Medical Care & Treatment
·         RARE Champion in Science
·         RARE Champion in Advocacy​
·         RARE Champion in Teen Advocacy​
·         RARE Champion, Collaborations in Advocacy
·         RARE Champion, Collaborations in Science & Technology
For more details on each award, please click here.Nominations close on April 30th.  Awards will be determined by nominees’ merit, not by number of submissions.

The 2015 Tribute to Champions of Hope Gala will take place September 26th at the Hyatt Regency Resort & Spa in Huntington Beach, CA. Winners will also be expected to attend an afternoon ceremony on September 25th.

Please email any questions or comments to Amy Grover at amyg@globalgenes.org

 

GGP-Rare_logo-tagline-v4_final
Global Genes is a 501(c)(3) nonprofit organization advocating for rare disease globally.

 

Day 4 Coverage of ENDO 2015

ENDO_2015

 

 

 

 

LB-OR02-Glucose Metabolism: From Bedside to Bench

A meta-analysis of the safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in Type 2 diabetes
CH Wysham, J Lin, L Kuritzky


Hypoglycemia in patients newly-initiated on basal insulin: Impact on treatment discontinuation
M Dalal, M Kazemi, F Ye


OR36-Metabolism and Gestational Diabetes

Impact of gestational diabetes on long-term vascular function
O Ajala, L Jensen, EA Ryan, CL Chik


OR40-Obesity: Human Studies in Body Weight Regulation

Increased protein intake during overfeeding increases energy expenditure, satiety, and urinary cortisol
A Graham, MC Schlogl, J Krakoff, MS Thearle


OR40-Obesity: Human Studies in Body Weight Regulation–Winner: Outstanding Abstract Award

Acute weight loss stimulates lipolysis and macrophage infiltration in the subcutaneous adipose tissue of obese women
JO Alemán, NM Iyengar, J Walker, J Gonzalez, GL Milne, DD Giri, CA Hudis, JL Breslow, PR Holt, AJ Dannenberg


OR44-Thyroid Cancer

Salvage therapy: When a tyrosine kinase inhibitor (TKI) fails in advanced medullary thyroid cancer (MTC)
SP Weitzman, KT Peicher, R Dadu, MI-N Hu, C Jimenez, C Gardner, A Qayyum, M Hernandez, ME Cabanillas


OR44-Thyroid Cancer – Winner: Outstanding Abstract Award

Phase II clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer
A Bikas, P Kundra, JA Wexler, M Mete, S Desale, L Wray, C Barett, B Clark, L Wartofsky, K Burman


OR45-What Is New in Vitamin D?

Bioavailable fractions are better markers than 25 hydroxy vitamin D for monitoring vitamin D status during pregnancy
MR Pandian, J Pandian, Z Seres, AN Elias


High dose vitamin D2 supplementation for a year does not cause serious adverse events including emergency room visits and hospitalizations in African American men with high burden of chronic disease
C Onochie, I Ciubotaru, A Domenico, Y Eisenberg, SC Kukreja, A Kouser, E Barengolts


OR45-What Is New in Vitamin D? – Winner: Outstanding Abstract Award

Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older and younger women: A comparison between Caucasians and African Americans in two randomized trials
SH Tella, JC Gallagher, S Yousefian, V Yalamanchili